Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

A double-blind, randomized, placebo-controlled crossover trial of the α2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis.

Herrick AL, Murray AK, Ruck A, Rouru J, Moore TL, Whiteside J, Hakulinen P, Wigley F, Snapir A.

Rheumatology (Oxford). 2014 May;53(5):948-52. doi: 10.1093/rheumatology/ket421. Epub 2014 Jan 31.

PMID:
24489014
2.
3.

Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.

Sallinen J, Holappa J, Koivisto A, Kuokkanen K, Chapman H, Lehtimäki J, Piepponen P, Mijatovic J, Tanila H, Virtanen R, Sirviö J, Haapalinna A.

Basic Clin Pharmacol Toxicol. 2013 Oct;113(4):239-49. doi: 10.1111/bcpt.12090. Epub 2013 Jun 20.

4.

Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenon.

Fava A, Wung PK, Wigley FM, Hummers LK, Daya NR, Ghazarian SR, Boin F.

Arthritis Care Res (Hoboken). 2012 Jun;64(6):925-9. doi: 10.1002/acr.21622. Epub 2012 Jan 24.

5.
6.

[Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].

Correa MJ, Mariz HA, Andrade LE, Kayser C.

Rev Bras Reumatol. 2014 Nov-Dec;54(6):452-8. doi: 10.1016/j.rbr.2014.07.001. Epub 2014 Aug 27. Portuguese.

7.

Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.

Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP.

J Rheumatol. 1992 Sep;19(9):1407-14.

PMID:
1279170
8.

Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis.

Schiopu E, Hsu VM, Impens AJ, Rothman JA, McCloskey DA, Wilson JE, Phillips K, Seibold JR.

J Rheumatol. 2009 Oct;36(10):2264-8. doi: 10.3899/jrheum.090270. Epub 2009 Sep 15.

PMID:
19755613
9.

Local cold exposure test with a new arterial photoplethysmographic sensor in healthy controls and patients with secondary Raynaud's phenomenon.

Hahn M, Hahn C, Jünger M, Steins A, Zuder D, Klyscz T, Büchtemann A, Rassner G, Blazek V.

Microvasc Res. 1999 Mar;57(2):187-98.

PMID:
10049666
11.

Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study.

Black CM, Halkier-Sørensen L, Belch JJ, Ullman S, Madhok R, Smit AJ, Banga JD, Watson HR.

Br J Rheumatol. 1998 Sep;37(9):952-60.

PMID:
9783759
12.

Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.

Wigley FM, Korn JH, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman M, Martin R, Collier DH, Weinstein A, Furst DE, Jimenez SA, Mayes MD, Merkel PA, Gruber B, Kaufman L, Varga J, Bell P, Kern J, Marrott P, White B, Simms RW, Phillips AC, Seibold JR.

Arthritis Rheum. 1998 Apr;41(4):670-7.

PMID:
9550476
13.

Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynaud's phenomenon.

Hayoz D, Bizzini G, Noël B, Depairon M, Burnier M, Fauveau C, Rouillon A, Brouard R, Brunner HR.

Rheumatology (Oxford). 2000 Oct;39(10):1132-8.

PMID:
11035135
14.

Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders.

Murray AK, Moore TL, Manning JB, Taylor C, Griffiths CE, Herrick AL.

Arthritis Rheum. 2009 Aug 15;61(8):1103-11. doi: 10.1002/art.24645.

15.
16.

The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon.

Friedman EA, Harris PA, Wood AJ, Stein CM, Kurnik D.

Clin Pharmacol Ther. 2007 Apr;81(4):503-9. Epub 2007 Feb 14.

PMID:
17301734
17.
18.

Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon.

Whitmore SE, Wigley FM, Wise RA.

J Rheumatol. 1995 Jan;22(1):50-4.

PMID:
7699682
19.
20.

Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.

Abou-Raya A, Abou-Raya S, Helmii M.

J Rheumatol. 2008 Sep;35(9):1801-8. Epub 2008 Aug 15.

PMID:
18709692

Supplemental Content

Support Center